Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/26724
Full metadata record
DC FieldValueLanguage
dc.contributor.authorZhu, Jasmine J-
dc.contributor.authorNaughton, William J-
dc.contributor.authorHay Be, Kim-
dc.contributor.authorEnsor, Nicholas-
dc.contributor.authorCheung, Ada S-
dc.date2021-06-01-
dc.date.accessioned2021-06-14T23:57:09Z-
dc.date.available2021-06-14T23:57:09Z-
dc.date.issued2021-06-01-
dc.identifier.citationEndocrinology, Diabetes & Metabolism Case Reports 2021; online first: 1 Juneen
dc.identifier.issn2052-0573
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/26724-
dc.description.abstractHypercalcaemia is a very common endocrine condition, yet severe hypercalcaemia as a result of fungal infection is rarely described. There are have only been two reported cases in the literature of hypercalcaemia associated with Cryptococcus infection. Although the mechanism of hypercalcaemia in these infections is not clear, it has been suggested that it could be driven by the extra-renal production of 1-alpha-hydroxylase by macrophages in granulomas. We describe the case of a 55-year-old woman with a 1,25-OH D-mediated refractory hypercalcaemia in the context of a Cryptococcus neoformans infection. She required treatment with antifungals, pamidronate, calcitonin, denosumab and high-dose glucocorticoids. A disseminated fungal infection should be suspected in immunosuppressed individuals presenting with hypercalcaemia. In immunocompromised patients with unexplained hypercalcaemia, fungal infections should be considered as the differential diagnoses; Glucocorticoids may be considered to treat 1,25-OH D-driven hypercalcaemia; however, the benefits of lowering the calcium need to be balanced against the risk of exacerbating an underlying infection; Fluconazole might be an effective therapy for both treatment of the hypercalcaemia by lowering 1,25-OH D levels as well as of the fungal infection.en
dc.language.isoeng
dc.titleRefractory hypercalcaemia associated with disseminated Cryptococcus neoformans infection.en
dc.typeJournal Articleen
dc.identifier.journaltitleEndocrinology, Diabetes & Metabolism Case Reportsen
dc.identifier.affiliationInfectious Diseasesen
dc.identifier.affiliationVictorian Liver Transplant Uniten
dc.identifier.affiliationMedicine (University of Melbourne)en
dc.identifier.doi10.1530/EDM-20-0186en
dc.type.contentTexten
dc.identifier.pubmedid34110303
local.name.researcherCheung, Ada S
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.languageiso639-1en-
item.grantfulltextnone-
item.openairetypeJournal Article-
item.cerifentitytypePublications-
crisitem.author.deptEndocrinology-
crisitem.author.deptSurgery-
crisitem.author.deptVictorian Liver Transplant Unit-
crisitem.author.deptEndocrinology-
crisitem.author.deptMedicine (University of Melbourne)-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

12
checked on Aug 24, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.